Combating Hepatitis C Virus by Targeting MicroRNA-122 Using Locked Nucleic Acids : The Therapeutic Sound of Silencing: Managing the Expectations on Targeting RNAiMACHLIN, Erica S; SARNOW, Peter; SAGAN, Selena M et al.Current gene therapy. 2012, Vol 12, Num 4, pp 301-306, issn 1566-5232, 6 p.Article

Exosomes and the Emerging Field of Exosome-Based Gene Therapy : The Therapeutic Sound of Silencing: Managing the Expectations on Targeting RNAiO'LOUGHLIN, Aisling J; WOFFINDALE, Caroline A; WOOD, Matthew J. A et al.Current gene therapy. 2012, Vol 12, Num 4, pp 262-274, issn 1566-5232, 13 p.Article

In Vivo Optical Imaging in Gene & Cell Therapy : In Vivo Imaging & Gene TherapyTANGNEY, Mark; FRANCIS, Kevin P.Current gene therapy. 2012, Vol 12, Num 1, pp 2-11, issn 1566-5232, 10 p.Article

MicroRNAs and the Warburg Effect: New Players in an Old Arena : The Therapeutic Sound of Silencing: Managing the Expectations on Targeting RNAiPING GAO; LINCHONG SUN; XIAOPING HE et al.Current gene therapy. 2012, Vol 12, Num 4, pp 285-291, issn 1566-5232, 7 p.Article

Retroviral Protein Transfer: Falling Apart to Make an Impact : Vectorizing mRNA and ProteinsMAETZIG, Tobias; BAUM, Christopher; SCHAMBACH, Axel et al.Current gene therapy. 2012, Vol 12, Num 5, pp 389-409, issn 1566-5232, 21 p.Article

Gene Therapy in Liver Diseases: State-of-the-Art and Future PerspectivesDOMVRI, Kalliopi; ZAROGOULIDIS, Paul; PORPODIS, Konstantinos et al.Current gene therapy. 2012, Vol 12, Num 6, pp 463-483, issn 1566-5232, 21 p.Article

Interference with Myostatin/ActRIIB Signaling as a Therapeutic Strategy for Duchenne Muscular DystrophyAMTHOR, Helge; HOOGAARS, Willem M. H.Current gene therapy. 2012, Vol 12, Num 3, pp 245-259, issn 1566-5232, 15 p.Article

Current Advances in Retroviral Gene TherapyYI, Youngsuk; MOON JONG NOH; KWAN HEE LEE et al.Current gene therapy. 2011, Vol 11, Num 3, pp 218-228, issn 1566-5232, 11 p.Article

Efficacy and Safety of Sleeping Beauty Transposon-Mediated Gene Transfer in Preclinical Animal Studies : Recombinase Technology for Gene TherapyHACKETT, Perry B; ARONOVICH, Elena L; HUNTER, David et al.Current gene therapy. 2011, Vol 11, Num 5, pp 341-349, issn 1566-5232, 9 p.Article

RNA Splicing Manipulation: Strategies to Modify Gene Expression for a Variety of Therapeutic OutcomesWILTON, Steve D; FLETCHER, Susan.Current gene therapy. 2011, Vol 11, Num 4, pp 259-275, issn 1566-5232, 17 p.Article

Therapeutic Applications of the PhiC31 Integrase System : Recombinase Technology for Gene TherapyCHAVEZ, Christopher L; CALOS, Michele P.Current gene therapy. 2011, Vol 11, Num 5, pp 375-381, issn 1566-5232, 7 p.Article

Experimental and Clinical Application of Plasmid DNA in the Field of Central Nervous Diseases : Naked Plasmid DNA for Gene TherapySHIMAMURA, Munehisa; SATO, Naoyuki; MORISHITA, Ryuichi et al.Current gene therapy. 2011, Vol 11, Num 6, pp 491-500, issn 1566-5232, 10 p.Article

Progress and Prospects of Polyplex Nanomicelles for Plasmid DNA Delivery : Naked Plasmid DNA for Gene TherapyITAKA, Keiji; KATAOKA, Kazunori.Current gene therapy. 2011, Vol 11, Num 6, pp 457-465, issn 1566-5232, 9 p.Article

AAV-Mediated Gene Supply for Treatment of Degenerative and Neovascular Retinal Diseases : AAV-Mediated Gene Therapy for the treatment of Retinal DiseaseCOLELLA, Pasqualina; AURICCHIO, Alberto.Current gene therapy. 2010, Vol 10, Num 5, pp 371-380, issn 1566-5232, 10 p.Article

Lactococcus lactis as a Cell Factory for Delivery of Therapeutic ProteinsBAHEY-EL-DIN, Mohammed; GAHAN, Cormac G. M; GRIFFIN, Brendan T et al.Current gene therapy. 2010, Vol 10, Num 1, pp 34-45, issn 1566-5232, 12 p.Article

In Vivo Application and Tracking of BaculovirusAIRENNE, Kari J; MAKKONEN, Kaisa-Emilia; MÄHÖNEN, Anssi J et al.Current gene therapy. 2010, Vol 10, Num 3, pp 187-194, issn 1566-5232, 8 p.Article

Cancer Electrogene Therapy with Interleukin-12CEMAZAR, Maja; JARM, Tomaz; SERSA, Gregor et al.Current gene therapy. 2010, Vol 10, Num 4, pp 300-311, issn 1566-5232, 12 p.Article

Electroporation Gene Therapy Preclinical and Clinical Trials for MelanomaHELLER, Loree C; HELLER, Richard.Current gene therapy. 2010, Vol 10, Num 4, pp 312-317, issn 1566-5232, 6 p.Article

Production, Purification and Characterization of Adeno-Associated VectorsAYUSO, Eduard; MINGOZZI, Federico; BOSCH, Fatima et al.Current gene therapy. 2010, Vol 10, Num 6, pp 423-436, issn 1566-5232, 14 p.Article

HIV-1 Gene Therapy at Pre-Integration and Provirus DNA LevelsNAZARI, Reza; JOSHI, Sadhna.Current gene therapy. 2009, Vol 9, Num 1, pp 20-25, issn 1566-5232, 6 p.Article

Prospects for Gene Therapy of OsteopetrosisASKMYR, Maria; FLORES, Carmen; FASTH, Anders et al.Current gene therapy. 2009, Vol 9, Num 3, pp 150-159, issn 1566-5232, 10 p.Article

Use of Genetically Modified Bacteria to Modulate Adaptive ImmunityBUENO, Susan M; GONZALEZ, Pablo A; KALERGIS, Alexis M et al.Current gene therapy. 2009, Vol 9, Num 3, pp 171-184, issn 1566-5232, 14 p.Article

Liver Directed Gene Therapy: A Long Road to Clinical ApplicationsFERRY, Nicolas.Current gene therapy. 2009, Vol 9, Num 2, issn 1566-5232, 90 p.Serial Issue

Advances in Interleukin-12 Gene Therapy for Acquired Liver DiseasesBERRAONDO, Pedro; PRIETO, Jesús; GONZALEZ-ASEGUINOLAZA, Gloria et al.Current gene therapy. 2009, Vol 9, Num 2, pp 62-71, issn 1566-5232, 10 p.Article

Towards Liver-Directed Gene Therapy for Crigler-Najjar SyndromeMONTENEGRO MIRANDA, Paula S; BOSMA, Piter J.Current gene therapy. 2009, Vol 9, Num 2, pp 72-82, issn 1566-5232, 11 p.Article